Hydrogen sulfide depletion contributes to microvascular remodeling in obesity

Am J Physiol Heart Circ Physiol. 2016 May 1;310(9):H1071-80. doi: 10.1152/ajpheart.00062.2016. Epub 2016 Mar 18.

Abstract

Structural remodeling of the microvasculature occurs during obesity. Based on observations that impaired H2S signaling is associated with cardiovascular pathologies, the current study was designed to test the hypothesis that altered H2S homeostasis is involved in driving the remodeling process in a diet-induced mouse model of obesity. The structural and passive mechanical properties of mesenteric resistance arterioles isolated from 30-wk-old lean and obese mice were assessed using pressure myography, and vessel H2S levels were quantified using the H2S indicator sulfidefluor 7-AM. Remodeling gene expression was assessed using quantitative RT-PCR, and histological staining was used to quantify vessel collagen and elastin. Obesity was found to be associated with decreased vessel H2S concentration, inward hypertrophic remodeling, altered collagen-to-elastin ratio, and reduced vessel stiffness. In addition, mRNA levels of fibronectin, collagen types I and III, matrix metalloproteinases 2 and 9, and tissue inhibitor of metalloproteinase 1 were increased and elastin was decreased by obesity. Evidence that decreased H2S was responsible for the genetic changes was provided by experiments in which H2S levels were manipulated, either by inhibition of the H2S-generating enzyme cystathionine γ-lyase with dl-propargylglycine or by incubation with the H2S donor GYY4137. These data suggest that, during obesity, depletion of H2S is involved in orchestrating the genetic changes underpinning inward hypertrophic remodeling in the microvasculature.

Keywords: extracellular matrix; hydrogen sulfide; microvascular; obesity; remodeling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkynes / pharmacology
  • Animals
  • Arterioles / drug effects
  • Arterioles / metabolism*
  • Arterioles / pathology
  • Arterioles / physiopathology
  • Cells, Cultured
  • Collagen / genetics
  • Collagen / metabolism
  • Collagenases / genetics
  • Collagenases / metabolism
  • Cystathionine gamma-Lyase / antagonists & inhibitors
  • Cystathionine gamma-Lyase / metabolism
  • Diet, High-Fat
  • Disease Models, Animal
  • Elastin / genetics
  • Elastin / metabolism
  • Enzyme Inhibitors / pharmacology
  • Fibronectins / genetics
  • Fibronectins / metabolism
  • Gene Expression Regulation
  • Glycine / analogs & derivatives
  • Glycine / pharmacology
  • Hydrogen Sulfide / metabolism*
  • Hypertrophy
  • Male
  • Mesentery / blood supply*
  • Mice, Inbred C57BL
  • Morpholines / metabolism
  • Morpholines / pharmacology
  • Obesity / genetics
  • Obesity / metabolism*
  • Obesity / pathology
  • Obesity / physiopathology
  • Organothiophosphorus Compounds / metabolism
  • Organothiophosphorus Compounds / pharmacology
  • Signal Transduction
  • Vascular Remodeling* / drug effects
  • Vascular Remodeling* / genetics
  • Vascular Stiffness

Substances

  • Alkynes
  • Enzyme Inhibitors
  • Fibronectins
  • GYY 4137
  • Morpholines
  • Organothiophosphorus Compounds
  • propargylglycine
  • Collagen
  • Elastin
  • Collagenases
  • Cystathionine gamma-Lyase
  • Glycine
  • Hydrogen Sulfide